Pre-Implantation Genetic Diagnosis (PGD) Market by Type and Application - Global Industry Analysis & Forecast to 2027
Published On : May 2022 Pages : 154 Category: Pharma & Healthcare Report Code : HC0511108
Pre-Implantation Genetic Diagnosis (PGD) Market by Type (Chromosomal Abnormalities, Aneuploidy, X-linked diseases, Single Gene Disorders, HLA Typing, Gender selection) Application (Fertility Clinics, Research) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Pre-Implantation Genetic Diagnosis (PGD) Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Pre-implantation genetic diagnosis is the genetic profiling of embryos prior to implantation and sometimes even of oocytes prior to fertilization. PGD is considered in a similar fashion to prenatal diagnosis.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
-
- Reprogenetics, LLC.
- F. Hoffmann-La Roche AG
- Genea Limited
- Illumina, Inc
- Laboratory Corporation of America Holdings
- Natera, Inc
- PerkinElmer, Inc
- Genesis Genetics Ltd
- Reproductive Genetics Innovations LLC.
- Quest Diagnostics Inc.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Pre-Implantation Genetic Diagnosis (PGD) Market, By Type, Estimates and Forecast, 2017-2027 ($Million)
o Chromosomal Abnormalities
o Aneuploidy
o X-linked diseases
o Single Gene Disorders
o HLA Typing
o Gender selection
· Pre-Implantation Genetic Diagnosis (PGD) Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Fertility Clinics
o Research
· Pre-Implantation Genetic Diagnosis (PGD) Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Reprogenetics, LLC.
o F. Hoffmann-La Roche AG
o Genea Limited
o Illumina, Inc
o Laboratory Corporation of America Holdings
o Natera, Inc
o PerkinElmer, Inc
o Genesis Genetics Ltd
o Reproductive Genetics Innovations LLC.
o Quest Diagnostics Inc.
· Pre-Implantation Genetic Diagnosis (PGD) Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Submarine Cables Market, By Country
o U.S. Submarine Cables Market
o Canada Submarine Cables Market
o Mexico Submarine Cables Market
o Europe
§ Europe Submarine Cables Market, By Country
o Germany Submarine Cables Market
o UK Submarine Cables Market
o France Submarine Cables Market
o Russia Submarine Cables Market
o Italy Submarine Cables Market
o Rest of Europe Submarine Cables Market
o Asia-Pacific
§ Asia-Pacific Submarine Cables Market, By Country
o China Submarine Cables Market
o Japan Submarine Cables Market
o South Korea Submarine Cables Market
o India Submarine Cables Market
o Southeast Asia Submarine Cables Market
o Rest of Asia-Pacific Submarine Cables Market
o South America
§ South America Submarine Cables Market
o Brazil Submarine Cables Market
o Argentina Submarine Cables Market
o Columbia Submarine Cables Market
o Rest of South America Submarine Cables Market
o Middle East and Africa
§ Middle East and Africa Submarine Cables Market
o Saudi Arabia Submarine Cables Market
o UAE Submarine Cables Market
o Egypt Submarine Cables Market
o Nigeria Submarine Cables Market
o South Africa Submarine Cables Market
o Rest of MEA Submarine Cables Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Pre-Implantation Genetic Diagnosis (PGD) Market, By Type
5.1. Introduction
5.2. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue and Market Share by Type (2017-2021)
5.2.1. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue and Revenue Share by Type (2017-2021)
5.3. Chromosomal Abnormalities
5.3.1. Global Chromosomal Abnormalities Revenue and Growth Rate (2017-2021)
5.4. Aneuploidy, X-linked diseases
5.4.1. Global Aneuploidy, X-linked diseases Revenue and Growth Rate (2017-2021)
5.5. Single Gene Disorders
5.5.1. Global Single Gene Disorders Revenue and Growth Rate (2017-2021)
5.6. HLA Typing
5.6.1. Global HLA Typing Revenue and Growth Rate (2017-2021)
5.7. Gender selection
5.7.1. Global Gender selection Revenue and Growth Rate (2017-2021)
6. Pre-Implantation Genetic Diagnosis (PGD) Market, By Applications
6.1. Introduction
6.2. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue and Market Share by Applications (2017-2021)
6.2.1. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue and Revenue Share by Applications (2017-2021)
6.3. Fertility Clinics
6.3.1. Global Fertility Clinics Revenue and Growth Rate (2017-2021)
6.4. Research
6.4.1. Global Research Revenue and Growth Rate (2017-2021)
7. Pre-Implantation Genetic Diagnosis (PGD) Market, By Region
7.1. Introduction
7.2. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue and Market Share by Regions
7.2.1. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue by Regions (2017-2021)
7.3. North America Pre-Implantation Genetic Diagnosis (PGD) by Countries
7.3.1. North America Pre-Implantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2017-2021)
7.3.2. North America Pre-Implantation Genetic Diagnosis (PGD) Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Pre-Implantation Genetic Diagnosis (PGD) by Countries
7.4.1. Europe Pre-Implantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2017-2021)
7.4.2. Europe Pre-Implantation Genetic Diagnosis (PGD) Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) by Countries
7.5.1. Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Pre-Implantation Genetic Diagnosis (PGD) by Countries
7.6.1. South America Pre-Implantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2017-2021)
7.6.2. South America Pre-Implantation Genetic Diagnosis (PGD) Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) by Countries
7.7.1. Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. Reprogenetics, LLC.
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. F. Hoffmann-La Roche AG
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Genea Limited
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Illumina, Inc
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Laboratory Corporation of America Holdings
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Natera, Inc
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. PerkinElmer, Inc
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Genesis Genetics Ltd
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Reproductive Genetics Innovations LLC.
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. Quest Diagnostics Inc.
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
9. Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2022-2027)
9.1. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Pre-Implantation Genetic Diagnosis (PGD) Market Forecast by Regions (2022-2027)
9.2.1. North America Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2022-2027)
9.2.1.1. United States Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2022-2027)
9.2.1.2. Canada Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2022-2027)
9.2.1.3. Mexico Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2022-2027)
9.2.2. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2022-2027)
9.2.2.1. Germany Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2022-2027)
9.2.2.2. France Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2022-2027)
9.2.2.3. UK Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2022-2027)
9.2.2.4. Russia Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2022-2027)
9.2.2.5. Italy Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2022-2027)
9.2.3. Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2022-2027)
9.2.3.1. China Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2022-2027)
9.2.3.2. Japan Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2022-2027)
9.2.3.3. Korea Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2022-2027)
9.2.3.4. India Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2022-2027)
9.2.4. South America Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2022-2027)
9.2.4.1. Brazil Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2022-2027)
9.2.4.2. Argentina Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2022-2027)
9.2.4.3. Columbia Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2022-2027)
9.2.4.4. Rest of South America Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2022-2027)
9.2.5. Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2022-2027)
9.2.5.3. Egypt Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2022-2027)
9.2.5.4. Nigeria Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2022-2027)
9.2.5.5. South Africa Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2022-2027)
9.2.5.6. Turkey Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2022-2027)
9.3. Pre-Implantation Genetic Diagnosis (PGD) Market Forecast by Type (2022-2027)
9.3.1. Pre-Implantation Genetic Diagnosis (PGD) Forecast by Type (2022-2027)
9.3.2. Pre-Implantation Genetic Diagnosis (PGD) Market Share Forecast by Type (2022-2027)
9.4. Pre-Implantation Genetic Diagnosis (PGD) Market Forecast by Applications (2022-2027)
9.4.1. Pre-Implantation Genetic Diagnosis (PGD) Forecast by Applications (2022-2027)
9.4.2. Pre-Implantation Genetic Diagnosis (PGD) Market Share Forecast by Applications (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Pre-Implantation Genetic Diagnosis (PGD) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Pre-Implantation Genetic Diagnosis (PGD) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Pre-Implantation Genetic Diagnosis (PGD) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Pre-Implantation Genetic Diagnosis (PGD) Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Pre-Implantation Genetic Diagnosis (PGD) Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Pre-Implantation Genetic Diagnosis (PGD) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Pre-Implantation Genetic Diagnosis (PGD) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Pre-Implantation Genetic Diagnosis (PGD) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Pre-Implantation Genetic Diagnosis (PGD) Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Pre-Implantation Genetic Diagnosis (PGD) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Pre-Implantation Genetic Diagnosis (PGD) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Pre-Implantation Genetic Diagnosis (PGD) Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Pre-Implantation Genetic Diagnosis (PGD) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Pre-Implantation Genetic Diagnosis (PGD) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Pre-Implantation Genetic Diagnosis (PGD) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Pre-Implantation Genetic Diagnosis (PGD) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Pre-Implantation Genetic Diagnosis (PGD) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Pre-Implantation Genetic Diagnosis (PGD) Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Pre-Implantation Genetic Diagnosis (PGD) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Pre-Implantation Genetic Diagnosis (PGD) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Pre-Implantation Genetic Diagnosis (PGD) Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Pre-Implantation Genetic Diagnosis (PGD) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Pre-Implantation Genetic Diagnosis (PGD) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Pre-Implantation Genetic Diagnosis (PGD) Revenue and Revenue Share by Type (2017-2019)
Figure Global Chromosomal Abnormalities Revenue and Growth Rate (2017-2019)
Figure Global Aneuploidy, X-linked diseases Revenue and Growth Rate (2017-2019)
Figure Global Single Gene Disorders Revenue and Growth Rate (2017-2019)
Figure Global HLA Typing Revenue and Growth Rate (2017-2019)
Figure Global Gender selection Revenue and Growth Rate (2017-2019)
Table Global Pre-Implantation Genetic Diagnosis (PGD) Revenue and Revenue Share by Applications (2017-2019)
Figure Global Fertility Clinics Revenue and Growth Rate (2017-2019)
Figure Global Research Revenue and Growth Rate (2017-2019)
Table Global Pre-Implantation Genetic Diagnosis (PGD) Revenue by Regions (2017-2019)
Figure North America Pre-Implantation Genetic Diagnosis (PGD) Growth Rate (2017-2019)
Figure North America Pre-Implantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2017-2019)
Figure North America Pre-Implantation Genetic Diagnosis (PGD) by Countries (2017-2019)
Figure North America Pre-Implantation Genetic Diagnosis (PGD) Revenue (Million USD) by Countries (2017-2019)
Figure United States Pre-Implantation Genetic Diagnosis (PGD) Growth Rate (2017-2019)
Figure United States Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Pre-Implantation Genetic Diagnosis (PGD) Growth Rate (2017-2019)
Figure Canada Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Pre-Implantation Genetic Diagnosis (PGD) Growth Rate (2017-2019)
Figure Mexico Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Pre-Implantation Genetic Diagnosis (PGD) Growth Rate (2017-2019)
Figure Europe Pre-Implantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2017-2019)
Figure Europe Pre-Implantation Genetic Diagnosis (PGD) by Countries (2017-2019)
Figure Europe Pre-Implantation Genetic Diagnosis (PGD) Revenue (Million USD) by Countries (2017-2019)
Figure Germany Pre-Implantation Genetic Diagnosis (PGD) Growth Rate (2017-2019)
Figure Germany Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Pre-Implantation Genetic Diagnosis (PGD) Growth Rate (2017-2019)
Figure France Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Pre-Implantation Genetic Diagnosis (PGD) Growth Rate (2017-2019)
Figure UK Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Pre-Implantation Genetic Diagnosis (PGD) Growth Rate (2017-2019)
Figure Russia Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Pre-Implantation Genetic Diagnosis (PGD) Growth Rate (2017-2019)
Figure Italy Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Pre-Implantation Genetic Diagnosis (PGD) Growth Rate (2017-2019)
Figure Rest of Europe Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Growth Rate (2017-2019)
Figure Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) by Countries (2017-2019)
Figure Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Revenue (Million USD) by Countries (2017-2019)
Figure China Pre-Implantation Genetic Diagnosis (PGD) Growth Rate (2017-2019)
Figure China Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Pre-Implantation Genetic Diagnosis (PGD) Growth Rate (2017-2019)
Figure Japan Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Pre-Implantation Genetic Diagnosis (PGD) Growth Rate (2017-2019)
Figure Korea Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Pre-Implantation Genetic Diagnosis (PGD) Growth Rate (2017-2019)
Figure India Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Growth Rate (2017-2019)
Figure Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Pre-Implantation Genetic Diagnosis (PGD) Growth Rate (2017-2019)
Figure South America Pre-Implantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2017-2019)
Figure South America Pre-Implantation Genetic Diagnosis (PGD) by Countries (2017-2019)
Figure South America Pre-Implantation Genetic Diagnosis (PGD) Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Pre-Implantation Genetic Diagnosis (PGD) Growth Rate (2017-2019)
Figure Brazil Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Pre-Implantation Genetic Diagnosis (PGD) Growth Rate (2017-2019)
Figure Argentina Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Pre-Implantation Genetic Diagnosis (PGD) Growth Rate (2017-2019)
Figure Columbia Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Pre-Implantation Genetic Diagnosis (PGD) Growth Rate (2017-2019)
Figure Rest of South America Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Growth Rate (2017-2019)
Figure Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) by Countries (2017-2019)
Figure Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Pre-Implantation Genetic Diagnosis (PGD) Growth Rate (2017-2019)
Figure Saudi Arabia Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Pre-Implantation Genetic Diagnosis (PGD) Growth Rate (2017-2019)
Figure United Arab Emirates Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Pre-Implantation Genetic Diagnosis (PGD) Growth Rate (2017-2019)
Figure Egypt Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Pre-Implantation Genetic Diagnosis (PGD) Growth Rate (2017-2019)
Figure Nigeria Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Pre-Implantation Genetic Diagnosis (PGD) Growth Rate (2017-2019)
Figure South Africa Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Pre-Implantation Genetic Diagnosis (PGD) Growth Rate (2017-2019)
Figure Turkey Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2017-2019)
Table Reprogenetics, LLC. Pre-Implantation Genetic Diagnosis (PGD) Financial Overview
Table F. Hoffmann-La Roche AG Pre-Implantation Genetic Diagnosis (PGD) Financial Overview
Table Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Financial Overview
Table Illumina, Inc Pre-Implantation Genetic Diagnosis (PGD) Financial Overview
Table Laboratory Corporation of America Holdings Pre-Implantation Genetic Diagnosis (PGD) Financial Overview
Table Natera, Inc Pre-Implantation Genetic Diagnosis (PGD) Financial Overview
Table PerkinElmer, Inc Pre-Implantation Genetic Diagnosis (PGD) Financial Overview
Table Genesis Genetics Ltd Pre-Implantation Genetic Diagnosis (PGD) Financial Overview
Table Reproductive Genetics Innovations LLC. Pre-Implantation Genetic Diagnosis (PGD) Financial Overview
Table Quest Diagnostics Inc. Pre-Implantation Genetic Diagnosis (PGD) Financial Overview
Figure Global Pre-Implantation Genetic Diagnosis (PGD) Revenue (Millions USD) and Growth Rate (2019-2027)
Table Pre-Implantation Genetic Diagnosis (PGD) Market Forecast by Regions (2019-2027)
Figure North America Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2019-2027)
Figure United States Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2019-2027)
Figure Canada Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2019-2027)
Figure Mexico Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2019-2027)
Figure Europe Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2019-2027)
Figure Germany Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2019-2027)
Figure France Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2019-2027)
Figure UK Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2019-2027)
Figure Russia Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2019-2027)
Figure Italy Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2019-2027)
Figure Rest of Europe Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2019-2027)
Figure Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2019-2027)
Figure China Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2019-2027)
Figure Japan Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2019-2027)
Figure Korea Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2019-2027)
Figure India Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2019-2027)
Figure Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2019-2027)
Figure South America Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2019-2027)
Figure Brazil Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2019-2027)
Figure Argentina Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2019-2027)
Figure Columbia Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2019-2027)
Figure Rest of South America Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2019-2027)
Figure Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2019-2027)
Figure Saudi Arabia Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2019-2027)
Figure United Arab Emirates Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2019-2027)
Figure Egypt Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2019-2027)
Figure Nigeria Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2019-2027)
Figure South Africa Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2019-2027)
Figure Turkey Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Market Forecast (2019-2027)
Figure Global Pre-Implantation Genetic Diagnosis (PGD) Forecast by Type (2019-2027)
Figure Global Pre-Implantation Genetic Diagnosis (PGD) Market Share Forecast by Type (2019-2027)
Figure Global Pre-Implantation Genetic Diagnosis (PGD) Forecast by Type (2019-2027)
Figure Global Pre-Implantation Genetic Diagnosis (PGD) Forecast by Applications (2019-2027)
Figure Global Pre-Implantation Genetic Diagnosis (PGD) Market Share Forecast by Applications (2019-2027)
Figure Global Pre-Implantation Genetic Diagnosis (PGD) Forecast by Applications (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|